% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

  • breezerwave breezerwave Mar 8, 2013 10:24 PM Flag

    Pfizer Stops Developing Hepatitis C Drug


    Pfizer Inc. has stopped development of an experimental hepatitis C drug, bowing out of a hotly contested industry race to introduce the next generation of treatments for the infectious liver disease.

    The New York-based drug giant decided to discontinue development of PF-00868554, also known as filibuvir, following a strategic review, said spokeswoman Victoria Davis. She said the decision wasn't related to any safety issues.

    The drug was in midstage clinical testing, further behind in development than potential new hepatitis C treatments from ..."

    Such facts make Vertex more valuable.

    Sentiment: Strong Buy

88.41+0.12(+0.14%)2:10 PMEDT